News

Public · Published

Wells Fargo maintains CRH at Overweight, lowers price target to $100 from $106

Wells Fargo kept its Overweight rating on CRH but lowered its price target to $100 from $106, a 5.7% decrease. The new target implies 10.4% upside from the October 29 close of $90.62.

Published:

Updated:

What happened

Wells Fargo kept its Overweight rating on CRH but lowered its price target to $100 from $106, a 5.7% decrease. The new target implies 10.4% upside from the October 29 close of $90.62.

Confirmed

Global impact / market context

A lower target signals the analyst still expects CRH shares to rise but sees less room than before. Because Wells Fargo still rates the stock Overweight, the change trims expected upside rather than reversing the positive view.

Analyst inference

Other recent analyst targets on CRH range from $105 to $135, all above the current share price. Wells Fargo's $100 target is now the lowest, which may make investors compare it with the more optimistic views.

Analyst inference

What to watch

  1. Wells Fargo's new $100 target sits below the $105 to $135 range from the other four recent analyst notes on CRH. Confirmed
  2. Watch whether other analysts cut their CRH targets toward Wells Fargo's $100 level, which would suggest a broader drop in expected upside. Analyst inference
  3. Track CRH's next earnings report for signs that revenue, costs, or capital spending explain why the analyst lowered the target. Proposed

Evidence

  • Original source link unavailable